After a tick bite in a tick-borne encephalitis virus endemic area:: Current positions about post-exposure treatment

被引:29
作者
Broekera, Michael [2 ]
Kollaritsch, Herwig [1 ]
机构
[1] Med Univ Vienna, Ctr Physiol & Pathophysiol, Inst Specif Prophylaxis & Trop Med, A-1090 Vienna, Austria
[2] Novartis Vaccines, Clin Res Dev & Med Affairs Dept, Marburg, Germany
关键词
TBE; post-exposure treatment; vaccination; immune-enhancement;
D O I
10.1016/j.vaccine.2007.11.046
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
If a person suffers a tick bite in tick-borne encephalitis (TBE) endemic areas, there is uncertainty on post-exposure treatment of naive (non-immune) persons in order to protect the patient against TBE. Particularly, there are no distinct positions on the use of TBE active immunization as post-exposure treatment. Of special concern is the possibility of antibody-dependent enhancement of infection and exacerbation of disease in case of post-exposure vaccination. Such phenomena have been reported for other flavivirus infections. In the past, immune globulin treatment was recommended, but these preparations are no longer available. Active immunization by using the current immunization schedules after a tick bite will. not result in appropriate neutralizing antibody concentrations within due time. Based on the assumptions that vaccination is not quick acting enough after a tick bite and that the theoretical risk of anti body-dependent enhancement cannot be excluded, no vaccination or other specific measure is currently recommended after a tick bite in non-vaccinated patients, leaving the patient in a completely dissatisfactory position. A risk/benefit analysis has been re-assessed for persons with a history with at least one vaccine injection, certain patient groups and in relation to the vaccination schedule which has been used and to the geographic area where the tick bite has occurred. In order to evaluate the value of the vaccine for post-exposure immunization, new immunization schedules have to be evaluated with respect to their capacity to induce antibodies more quickly. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:863 / 868
页数:6
相关论文
共 31 条
[1]  
AEBI C, 1994, SCHWEIZ MED WSCHR, V124, P1837
[2]   Do specific hyperimmunoglobulins aggravate clinical course of tick-borne encephalitis? [J].
Arras, C ;
Fescharek, R ;
Gregersen, JP .
LANCET, 1996, 347 (9011) :1331-1331
[3]   History of TBE vaccines [J].
Barrett, PN ;
Schober-Bendixen, S ;
Ehrlich, H .
VACCINE, 2003, 21 :S41-S49
[4]  
Broker Michael, 2003, Travel Med Infect Dis, V1, P181, DOI 10.1016/j.tmaid.2003.07.001
[5]  
GHEM HE, 2007, P ANN M SWISS SOC PA
[6]   FLAVIVIRUS INFECTION ENHANCEMENT IN MACROPHAGES - RADIOACTIVE AND BIOLOGICAL STUDIES ON THE EFFECT OF ANTIBODY ON VIRAL FATE [J].
GOLLINS, SW ;
PORTERFIELD, JS .
JOURNAL OF GENERAL VIROLOGY, 1984, 65 (AUG) :1261-1272
[7]   A RANDOMIZED PHASE-II STUDY OF A NEW TICK-BORNE ENCEPHALITIS VACCINE USING 3 DIFFERENT DOSES AND 2 IMMUNIZATION REGIMENS [J].
HARABACZ, I ;
BOCK, H ;
JUNGST, C ;
KLOCKMANN, U ;
PRAUS, M ;
WEBER, R .
VACCINE, 1992, 10 (03) :145-150
[8]   ENHANCEMENT OF INFECTIVITY OF ARBOVIRUSES BY SPECIFIC ANTISERA PRODUCED IN DOMESTIC FOWLS [J].
HAWKES, RA .
AUSTRALIAN JOURNAL OF EXPERIMENTAL BIOLOGY AND MEDICAL SCIENCE, 1964, 42 (04) :465-+
[9]   Field effectiveness of vaccination against tick-borne encephalitis [J].
Heinz, Franz X. ;
Holzmann, Heidemarie ;
Essl, Astrid ;
Kundi, Michael .
VACCINE, 2007, 25 (43) :7559-7567
[10]  
*IMPFPL, 2007, OST EMPF OBERST SAN